Navigation Links
Ethicon And DePuy Synthes Introduce Customized Wound Closure Kits Aiming To Improve Efficiencies And Patient Outcomes In Orthopaedic Surgery
Date:3/13/2017

SOMERVILLE, N.J., March 13, 2017 /PRNewswire/ -- Today, Ethicon* and DePuy Synthes are joining forces to introduce customized wound closure kits for orthopaedic surgery. The new wound closure kits, which include Ethicon's innovative wound closure products STRATAFIX™ Knotless Tissue Control Devices and DERMABOND® PRINEO® Skin Closure System, allow for complete customization and are now available through DePuy Synthes in the U.S.

As the need for standardization and efficiency in the operating room becomes increasingly important, these customized wound closure kits may help health systems meet their Triple Aim goals of reducing costs, enhancing patient outcomes and increasing patient satisfaction.

Orthopaedic surgeons are now able to choose which sutures they would like by each layer of closure, packaged in one convenient kit for specific procedures, designed to provide standardization and efficiency in the operating room.  The advanced technology of STRATAFIX Knotless Tissue Control Devices and DERMABOND PRINEO System also helps to achieve greater procedural efficiencies during wound closure. The Ethicon wound closure kits will be assembled and supplied by Medical Action Industries, an Owens & Minor Company, a leading provider of procedure-based kits and trays.

"DePuy Synthes' extensive reach in the orthopaedics space will enable us to bring the benefits of Ethicon's advanced wound closure products to many more health systems and sites of care," says Gary Fischetti, Company Group Chairman, North America Region, Johnson & Johnson Medical Devices Companies. "The launch of our wound closure kit demonstrates just one of the new ways we are partnering across our medical devices businesses to provide efficient capabilities that streamline procedures, and may lead to better outcomes for the millions of patients who undergo surgery each year."

The Benefits of Advanced Wound Closure Technology

With its latest wound closure innovations, STRATAFIX Knotless Tissue Control Devices and DERMABOND PRINEO System, Ethicon continues to lead the way  in wound closure that is helping to improve efficiencies in the OR, reduce wound closure time and optimize healing for patients.  STRATAFIX Knotless Tissue Control Devices provide more strength and security, more consistency and more efficiency than traditional suture.i  The portfolio of STRATAFIX Knotless Tissue Control Devices also enables surgeons to more easily manage tension and control tissue approximation with each pass during closure and eliminates the need to tie knots.i  As a replacement for sutures or staples, DERMABOND PRINEO System provides minimally invasive closure – no holes in the skin; no sutures or staples to remove, and no dressing changes, which may potentially reduce follow-up visits and support good cosmetic results for patients.ii,iii

STRATAFIX Knotless Tissue Control Devices and DERMABOND PRINEO System also offer the additional benefits of addressing some of the risk factors associated with Surgical Site Infections (SSIs). Addressing the risk factors associated with SSI's has never been more important, now that the costs resulting from some hospital-acquired infections are no longer reimbursed by Medicare.  The DERMABOND PRINEO System has been shown in vitro to provide a microbial barrier that provides protection against organisms commonly responsible for SSIs.iii   The portfolio of STRATAFIX Knotless Tissue Control Devices offers sutures with Ethicon Plus antibacterial triclosan coating. Plus Sutures have been proven in vivo to kill bacteria on the suture known to be associated with SSIs.iv, v

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.

About DePuy Synthes Companies
DePuy Synthes Companies, part of the Johnson & Johnson Family of Companies, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes Companies solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.

About Ethicon
From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon, part of the Johnson & Johnson Family of Companies, has made significant contributions to surgery for more than 60 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world's most pressing health care issues, and improve and save more lives. Through Ethicon's surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at www.ethicon.com and follow us on Twitter @Ethicon.

* Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC and certain of their affiliates. Ethicon, Inc. is the legal manufacturer of STRATAFIX™ and DERMABOND® PRINEO®. All other trademarks are the property of their respective owners.

i Data on file, Ethicon, Inc.: STRATAFIX Claims Matrix SFX-308-12. 2013.
ii Ethicon Inc. DERMABOND PRINEO Skin Closure System (22cm) Instructions for Use. LAB100114233v2. 5/15
iii Data on File, Ethicon Inc (2013) DERMABOND PRINEO Skin Closure System Matrix. 043364-151113
iv Ming X, Rothenburger S, Nichols MM. In vivo and invitro antibacterial efficacy of PDS Plus (polidioxanone with triclosan) suture. Surg Infect. 2008;9(4):451-457.
v Ming X, Rothenburger S, Yang D. In vitro antibacterial efficacy of Monocryl Plus Antibacterial Suture (poligelcaprone 25 with triclosan). Surg Infect. 2007;8(2):201-207.

068291-170302

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ethicon-and-depuy-synthes-introduce-customized-wound-closure-kits-aiming-to-improve-efficiencies-and-patient-outcomes-in-orthopaedic-surgery-300422083.html


'/>"/>
SOURCE Ethicon
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases
2. Transvaginal Mesh Lawsuit Latest Update News: J&Js Ethicon Loses another Mesh Trial
3. Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker
4. Global Laparoscopic Devices Market 2014-2018: Key Vendors are Cardinal Health, Covidien, Ethicon Endo-Surgery, KARL STORZ, Olympus Europa and Stryker
5. Global Minimally Invasive Surgical Instruments Market 2015-2019: Medtronic, Smith & Nephew, Aesculap, Ethicon & Stryker Dominates the $14 Billion Industry
6. Transvaginal Mesh News: $5.7MM Verdict Reached against Johnson & Johnsons Ethicon Subsidiary, Says Lawsuitsettlementnews.com
7. Legal-Bay Lawsuit Settlement Funding Announces $5.7MM Verdict against Johnson & Johnsons Ethicon Subsidiary
8. United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating
9. Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators
10. Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding
11. Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized as a ... for the fourth year in a row. 1 ... the Leaders quadrant have the highest scores for their Ability ... Leaders quadrant has the market share, credibility, and marketing and ... These vendors demonstrate a clear understanding of market needs; they ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with ... to schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing ... directory will bring more Six Month Smiles patients to their providers.” , Each month, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... , ... July 25, 2017 , ... Summers in Palm ... the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high fun. ... shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and sorbet ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance ... services to communities across North Carolina, is launching a charity event in conjunction ... support for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy ...
Breaking Medicine News(10 mins):